Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing IVF/ICSI

Esta versión no es la más reciente

ver la versión actual 04 enero 2024

Información

DOI:
https://doi.org/10.1002/14651858.CD012693Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 19 junio 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Ginecología y fertilidad

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Sarah F Lensen

    Correspondencia a: Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand

    [email protected]

  • Jack Wilkinson

    Centre for Biostatistics, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester, UK

  • Ben Willem J Mol

    Discipline of Obstetrics and Gynaecology, School of Medicine, Robinson Research Institute, The University of Adelaide, Adelaide, Australia

  • Antonio La Marca

    Mother‐Infant Department, University of Modena and Reggio Emilia, Clinica Eugin, Modena, Italy

  • Helen Torrance

    Department of Reproductive Medicine and Gynecology, University Medical Center, Utrecht, Netherlands

  • Frank J Broekmans

    Department of Reproductive Medicine and Gynecology, University Medical Center, Utrecht, Netherlands

Contributions of authors

SL and JW developed the protocol and search strategies, with input and final approval from all authors.
All authors read and commented on the draft versions of the protocol, and approved the final version.

Sources of support

Internal sources

  • None, Other.

External sources

  • NIHR Cochrane Incentive Award, UK.

    The award is made available at submission of the completed review within the agreed timeframe.

Declarations of interest

Sarah Lensen does not have any conflicts of interest to declare.

Ben Mol has received consultancy fees for ObsEva, Guerbet and Merck.

Jack Wilkinson is funded by a Doctoral Research Fellowship supported by the National Institute for Health Research (DRF‐2014‐07‐050). The views expressed in this publication are those of the authors and not necessarily those of the National Health Service (NHS), the National Institute for Health Research or the Department of Health. JW also declares that publishing research is beneficial to his career.

Antonio La Marca has received a consultation fee from Merck Serono, Ferring and MSD.

Frank Broekmans has received monetary compensation: member of the external advisory board for Merck Serono and Ferring, the Netherlands; educational activities for Ferring BV, the Netherlands; consultancy work for Gedeon Richter, Belgium; strategic cooperation with Roche on automated AMH assay development and research cooperation with Ansh Labs.

Frank Broekmans, Ben Mol and Helen Torrance are investigators in the OPTIMIST trial which is likely to be included in this review (van Tilborg 2012). Frank Broekmans is an investigator on another trial likely to be included in this review (Klinkert 2005). To manage this potential conflict, review authors will not extract data or assess risk of bias for the studies they have been involved with.

Acknowledgements

We thank the Cochrane Gynaecology and Fertility Group. In particular, we are grateful to Marian Showell (Information Specialist) for her assistance in developing the search strategies.

Version history

Published

Title

Stage

Authors

Version

2024 Jan 04

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)

Review

Olina Ngwenya, Sarah F Lensen, Andy Vail, Ben Willem J Mol, Frank J Broekmans, Jack Wilkinson

https://doi.org/10.1002/14651858.CD012693.pub3

2018 Feb 01

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)

Review

Sarah F Lensen, Jack Wilkinson, Jori A Leijdekkers, Antonio La Marca, Ben Willem J Mol, Jane Marjoribanks, Helen Torrance, Frank J Broekmans

https://doi.org/10.1002/14651858.CD012693.pub2

2017 Jun 19

Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing IVF/ICSI

Protocol

Sarah F Lensen, Jack Wilkinson, Ben Willem J Mol, Antonio La Marca, Helen Torrance, Frank J Broekmans

https://doi.org/10.1002/14651858.CD012693

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Female; Humans; Pregnancy;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.